3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is ever more attracting researcher attention due to limited data suggesting unique pharmacological characteristics. Present studies demonstrate that 3-HPC may display separate impacts on the brain nervous system, possibly playing a role to some of the unexpected manifestations rel